1. Home
  2. PRE vs ZNTL Comparison

PRE vs ZNTL Comparison

Compare PRE & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prenetics Global Limited

PRE

Prenetics Global Limited

HOLD

Current Price

$15.47

Market Cap

295.3M

Sector

Industrials

ML Signal

HOLD

Logo Zentalis Pharmaceuticals Inc.

ZNTL

Zentalis Pharmaceuticals Inc.

HOLD

Current Price

$4.09

Market Cap

313.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRE
ZNTL
Founded
2014
2014
Country
Hong Kong
United States
Employees
285
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
295.3M
313.9M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
PRE
ZNTL
Price
$15.47
$4.09
Analyst Decision
Strong Buy
Buy
Analyst Count
2
5
Target Price
$30.50
$6.60
AVG Volume (30 Days)
176.0K
1.1M
Earning Date
06-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.03
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$108.69
N/A
Revenue Next Year
$58.68
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.15
$1.13
52 Week High
$23.63
$6.95

Technical Indicators

Market Signals
Indicator
PRE
ZNTL
Relative Strength Index (RSI) 38.53 50.58
Support Level $14.67 $3.75
Resistance Level $17.76 $4.34
Average True Range (ATR) 1.28 0.30
MACD 0.03 -0.06
Stochastic Oscillator 12.64 26.72

Price Performance

Historical Comparison
PRE
ZNTL

About PRE Prenetics Global Limited

Prenetics Global Ltd is a health sciences company dedicated to advancing consumer health. The consumer initiative is led by IM8, one of the world's fastest-growing supplement brands; Europa, one of the sports distribution companies in the USA; and CircleDNA, a direct-to-consumer DNA testing company. As the first consumer healthcare company to establish a Bitcoin treasury with its initial approximately $20 million Bitcoin purchase and board-approved comprehensive Bitcoin plan of action, Prenetics is pioneering the intersection of healthcare innovation and digital asset adoption.

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.

Share on Social Networks: